Highly significant suppression of the growth of S1509a and Sa-I syngeneic sarcomas was observed in A/J mice following daily intravenous injections of 2 ;&l of anti-I-Jk alloantiserum. This effect persisted as long as the anti-I-Jk serum was administered (day 15). In contrast, a control anti-I-Js serum had no discernible effect on the growth of the S1509a tumor. The inhibitory activity of the anti-I-k serum on the growth of the tumor was absorbed specifically by B10BR spleen cells bearing I-Jk determinants. In other experiments, we established that A/J mice treated with anti-I-Jk serum, according to the protocol described above, are no longer a source of tumor-specific suppressor cells for adoptive transfer into immune tumor-bearing recipient mice. We conclude that anti-I-Jk serum inhibits tumor growth in A/J mice by abolishing tumor-specific suppressor activity.The failure of the host to mount an effective immune response against growing syngeneic, yet demonstrably antigenic, tumors has been attributed to complex tumor and host factors that protect the tumor against the immune defenses of the host. One of the mechanisms favoring tumor growth is the development of specific suppressor thymus-derived (T) cells. Recent studies of the host reaction to murine syngeneic tumors have established that a progressively growing methylchloranthrene-induced fibrosarcoma stimulates the development, within the lymphoid organs, of T cells capable of suppressing the immune rejection of the tumor (1, 2). Furthermore, such suppressor T cells were shown to produce tumor-specific H-2 coded products with tumor-enhancing properties (3). This tumor-specific suppressor T cell factor and other specific T cell factors capable of suppressing antibody responses (4-6) or contact sensitivity (7, 8) have similar biological and immunochemical properties. Suppressor T cells (9) and specific suppressor factors (8, 10, 11) bear determinants coded for by the I-J subregion of the H-2 complex not displayed on other T cells or other immunological regulatory factors.Anti-I-J antisera could, therefore, be expected to behave as highly effective antisuppressor agents in vivo. Recent studies by Pierres et al. (12) in our laboratory have investigated the effect of anti-I-J alloantisera, administered intravenously, on the antibody response to suboptimal doses of sheep erythrocytes (SRBC). The injection of microliter quantities of anti-I-Jk antisera regularly and significantly enhanced IgM and IgG responses of A/J mice to SRBC (12). Prompted by these results, we investigated the effect of anti-I-J antisera on the growth of syngeneic methylcholanthrene-induced sarcomas S1509a and